Request to Divide

KORLYM

CORCEPT THERAPEUTICS INCORPORATED

Request to Divide

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form No Form Number (Rev 12/2015)
OMB No. 0651-0054 (Exp 10/31/2017)

Trademark/Service Mark Request to Divide


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88282423
LAW OFFICE ASSIGNED LAW OFFICE 101
EXTENSION OF USE YES
MARK SECTION
MARK KORLYM
REQUEST TO DIVIDE YES
GOOD(S)/SERVICE(S) IN USE Pharmaceutical preparations for the treatment of oncologic, metabolic, and ophthalmic diseases and disorders (Class 05)
GOOD(S)/SERVICES INTENT TO USE Pharmaceutical preparations for the treatment of cardiovascular and gastroenterlogic diseases and disorders (Class 05)
SECTION 1(a) GOOD(S)/SERVICE(S) The applicant requests that the good(s)/service(s) based on use in commerce move to registration at this time.
SECTION 1(a) GOOD(S)/SERVICE(S) ADDITIONAL INFORMATION
SIGNATURE SECTION
DECLARATION SIGNATURE /charles robb/
SIGNATORY'S NAME Charles Robb
SIGNATORY'S POSITION Chief Financial Officer
DATE SIGNED 01/14/2020
REQUEST TO DIVIDE SIGNATURE /julie dalke/
SIGNATORY'S NAME Julie Dalke
SIGNATORY'S POSITION Attorney of Record, CA bar member
DATE SIGNED 01/14/2020
AUTHORIZED SIGNATORY YES
PAYMENT SECTION
NUMBER OF CLASSES IN USE 1
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] 100
REQUEST TO DIVIDE FEE 100
TOTAL AMOUNT 475
PAYMENT METHOD CC
FILING INFORMATION
SUBMIT DATE Tue Jan 14 17:18:25 EST 2020
TEAS STAMP USPTO/SOU-XXX.XXX.X.XXX-2
0200114171825921773-88282
423-700e0be51c3938634394e
2df7e969abf35a34e8a8f9ad6
b45845e7369722f2770-CC-18
246775-202001141703263777
99



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form No Form Number (Rev 12/2015)
OMB No. 0651-0054 (Exp 10/31/2017)


Trademark/Service Mark Request to Divide


To the Commissioner for Trademarks:

MARK: KORLYM
SERIAL NUMBER: 88282423




REQUEST TO DIVIDE
The applicant is requesting to divide the application and specifies the following:
The following good(s) or service(s) is/are now in use: Pharmaceutical preparations for the treatment of oncologic, metabolic, and ophthalmic diseases and disorders (Class 05)
The following good(s) or service(s) remain(s) under the Section 1(b), intent to use basis: Pharmaceutical preparations for the treatment of cardiovascular and gastroenterlogic diseases and disorders (Class 05)
The applicant requests that the good(s)/service(s) based on use in commerce move to registration at this time.
Section 1(a) Good(s)/Service(s) Additional Information:






A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.

A fee payment in the amount of $100 will be submitted with the form, representing payment for the request to divide fee.

A fee payment in the amount of $275 will be


Declaration


The signatory believes that the applicant is the owner of the mark sought to be registered.
For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified.
For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified.
For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.


Signature: /charles robb/      Date Signed: 01/14/2020
Signatory's Name: Charles Robb
Signatory's Position: Chief Financial Officer

Request to Divide Signature:

Signature: /julie dalke/      Date Signed: 01/14/2020
Signatory's Name: Julie Dalke
Signatory's Position: Attorney of Record, CA bar member

Serial Number: 88282423
Internet Transmission Date: Tue Jan 14 17:18:25 EST 2020
TEAS Stamp: USPTO/SOU-XXX.XXX.X.XXX-2020011417182592
1773-88282423-700e0be51c3938634394e2df7e
969abf35a34e8a8f9ad6b45845e7369722f2770-
CC-18246775-20200114170326377799



Request to Divide [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed